Cocaine and alcohol interactions in naive and alcohol-pretreated rats

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 807-812

  Hedaya, Mohsen A ^a   Pan, Wei Jian ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZOYLECGONINE; DRUG METABOLITE; HOMOCOCAINE; SODIUM CHLORIDE;

ALCOHOL ABUSE; ANIMAL MODEL; AREA UNDER THE CURVE; DOSE TIME EFFECT RELATION; DRUG ABUSE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG METABOLISM; HALF LIFE TIME; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SHORT SURVEY; SUBSTANCE ABUSE;

ALCOHOLISM; ANIMALS; COCAINE; CROSS-OVER STUDIES; DRUG INTERACTIONS; ETHANOL; MALE; RATS; RATS, WISTAR; SUBSTANCE-RELATED DISORDERS;

EID: 0030035127     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. T. Randall: Cocaine, alcohol mix in body to form even longer lasting, more lethal drug. JAMA 267, 1043-1044 (1992).
2. A. M. Washton and M. S. Gold: Recent trends in cocaine abuse: a review from the national hotline 800-cocaine. Adv. Alcohol Substance Abuse 6, 31-47 (1986).
3. W. L. Hearn, D. D. Flynn, G. W. Hime, S. Rose, J. C. Cofino, E. Mantero-Atienza, C. V. Wetli, and D. C. Mash: Cocaethylene: a unique cocaine metabolite displays high affinity to the dopamine transporter. J. Neurochem. 56, 698-701 (1991).
4. F. K. Rafla and R. L. Epstein: Identification of cocaine and its metabolites in human urine in the presence of ethyl alcohol. J. Anal. Toxicol. 3, 59-63 (1979).
5. R. M. Smith: Ethyl esters of arylhydroxy and arylhydroxymethoxycocaine in the urines of simultaneous cocaine and ethanol users. J. Anal. Toxicol. 8, 38-42 (1984).
6. N. L. Benowitz: Clinical pharmacology and toxicology of cocaine. Pharmacol. Toxicol. 72, 3-12 (1993).
7. M. Farre, R. Torre, M. Llorente, X. Lamas, B. Ugena, J. Segura, and J. Cami: Alcohol and cocaine interaction in humans. J. Pharmacol. Exp. Ther. 266, 1364-1373 (1993).
8. M. Perez-Reyes and R. Jeffcoat: Ethanol/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relation to subjective and cardiovascular effects. Life Sci. 51, 553-563 (1992).
9. E. F. McCance-Katz, L. H. Price, C. J. McDougle, T. R. Kosten, J. E. Black, and P. I. Jatlow: Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology 111, 39-46 (1993).
10. C. S. Boyer and D. R. Petersen: Enzymatic basis of the esterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther. 260, 939-246 (1992).
11. P. I. Jatlow: Cocaethylene: pharmacologic activity and clinical significance. Ther. Drug Monit. 15, 533-536 (1993).
12. P. I. Jatlow, J. D. Elsworth, C. W. Bradberry, G. Winger, J. R. Taylor, R. Russell, and R. H. Roth: Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 48, 1787-1794 (1991).
13. J. J. Woodward, R. Mansbach, F. I. Carroll, and R. L. Balster: Cocaethylene inhibits dopamine uptake and produces cocaine-like actions in drug discrimination studies. Eur. J. Pharmacol. 197, 235-236 (1991).
14. S. M. Roberts, R. D. Harbison, and R. C. James: Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. Drug Metab. Dispos. 21, 537-541 (1993).
15. C. S. Lieber: Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol. Clin. Exp. Res. 15, 573-592 (1991).
16. C. S. Yang, J. F. Brady, and J. Hong: Dietary effects on cytochrome P450, xenobiotic metabolism and toxicity. FASEB 6, 737-744 (1992).
17. D. R. Koop: Oxidative and reductive metabolism by cytochrome P4502E1. FASEB 6, 724-730 (1992).
18. J. L. Raucy, J. C. Kraner, and J. M. Lasker: Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23, 1-20 (1993).
19. S. Rose, W. L. Hearn, G. W. Hime, C. V. Wetli, A. J. Ruttenber, and D. C. Mash: Cocaine and cocaethylene concentrations in human post mortem cerebral cortex. Neurosci. Abstr. 16, 14 (abstr. 11.6) (1990).
20. R. P. Roine, R. T. Gentry, R. T. Lim, E. Baraona, and C. S. Lieber: Effect of concentration of ingested ethanol on blood alcohol levels. Alcohol. Clin. Exp. Res. 15, 734-738 (1991).
21. University of Washington: "Material Safety Data Sheet: Laboratory Safety System, Environmental Health and Safety." University of Washington, Seattle, 1995.
22. Abbott Diagnostics: "ADx Operator's Guide." Abbot Diagnostics, Chicago, IL, 1989.
23. D. Weiner and K. Metzler: "PCNONLIN," version 4.0. SCI Statistical Consultants, Inc., Lexington, KY, 1992.
24. R. T. Lim, R. T. Gentry, D. Ito, H. Yokoyama, E. Baraona, and C. S. Lieber: First-pass metabolism of ethanol is predominantly gastric. Alcohol. Clin. Exp. Res. 17, 1337-1344 (1993).
25. M. Gibaldi and D. Perrier: "Pharmacokinetics," 2nd ed. Marcel Dekker, New York, 1982.
26. J. B. Nobiletti, P. I. Jatlow, and C. W. Bradberry: Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies. Psychopharmacology 116, 273-278 (1994).
27. C. E. Lau, A. Imam, F. Ma, and J. L. Falk: Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J. Pharmacol. Exp. Ther. 257, 444-456 (1991).
28. S. M. Roberts, D. L. Phillips, and I. R. Tebbett: Increased blood and brain cocaine concentrations with ethanol cotreatment in mice. Drug Metab. Dispos. 23, 664-666 (1995).
29. R. A. Dean, C. D. Christian, R. H. Barry Sample, and W. F. Bosron: Human liver cocaine esterase: ethanol mediated formation of ethylcocaine. FASEB 5, 2735-2739 (1991).
30. M. R. Brzezinski, T. L. Abraham, C. L. Stone, R. A. Dean, and W. F. Bosron: Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of cocaethylene from alcohol and cocaine. Biochem. Pharmacol. 48, 1747-1755, (1994).